Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Sep 25, 2020 5:21pm

188 Views

Post# 31624062

RE:RE:RE:RE:It’s also nice

baystock1 wrote:

BencrosMum wrote:
sounded like finished finished to me. Pretty much direct quote "we have/there is enough money to finish phase 2"

hopefully we're above .20 by the end of the trial, wouldn't mind doing another raise at 2 or 3 bucks

NeilPaert74 wrote:

BencrosMum wrote: That they confirmed there is enough money to finish phase 2.

Mom, is that finished finished? Or are they expecting to close down phase 2 once they achieve BTD with Accelerated Approval(commercialization)? Then they would need money to ramp up production and sales.

I'm still expecting another financing next year. Yet, I'm hoping they find some Covid 19 money $$ or a JV to help them out.

I don't think anyone really believes that the company has enough money to last thru the end of phase 2. That is the primary reason for the low share price...fear of another disastrous financing that collapses the share price again. IMO they will need to do another financing before mid 2021. I would love to hear arguments to the contrary.

Well there you have it then. The low share price already factors in another financing. So if there is another financing the only way we can go is up right?

Bullboard Posts

How one company is disrupting PoC testing